Covidence vs Rayyan vs Elicit vs INRA: which systematic review tool should you use?
Covidence, Rayyan, Elicit, and INRA all help with systematic review work, but they solve different problems. The right choice depends on whether you need institutional review management, fast screening, AI evidence discovery, or a workflow that carries papers through synthesis and writing.
Marwan Taman
Founder & CEO, INRA.AI
Short answer: choose Covidence for established institutional systematic review management, Rayyan for accessible screening, Elicit for AI search and extraction, and INRA when you want systematic review work connected to source-backed synthesis and writing.
Quick comparison
Covidence
Institutional review teams that want a familiar, structured review workflow.
Watch out: Individual pricing is higher than lightweight tools, and teams may still need other products for discovery and writing.
Rayyan
Fast title and abstract screening, especially when budget and accessibility matter.
Watch out: The strongest AI and team controls sit behind paid or institutional plans.
Elicit
AI-assisted search, paper summaries, extraction tables, and early evidence mapping.
Watch out: It is strongest as an AI research assistant, not a traditional review management system.
INRA
Researchers who want AI support across screening, full-text review, extraction, risk of bias, synthesis, and writing.
Watch out: It is newer than Covidence and Rayyan, so institutional track record is still building.
How the tools differ
The biggest mistake is comparing these tools as if they were interchangeable. Covidence and Rayyan grew up around systematic review management and screening. Elicit grew up around AI-assisted evidence discovery. INRA sits closer to the full research workflow: review management, synthesis, citation verification, and report writing.
Systematic review software vs AI literature review tools
A better way to compare the category is to separate systematic review software from AI literature review tools. Systematic review software is built around protocol-led decisions: imports, screening, full-text eligibility, extraction, risk of bias, and PRISMA reporting. AI literature review tools are usually better for discovery, summarization, evidence mapping, and early synthesis.
That distinction matters because a team choosing between Covidence, Rayyan, Elicit, and INRA may be solving different problems. If the bottleneck is reviewer workflow and auditability, start with systematic review software. If the bottleneck is finding and understanding the evidence landscape, AI literature review tools may help earlier in the process. For teams that need both, the stronger fit is an AI-assisted evidence synthesis workflow that keeps sources, decisions, and writing connected.
| Criterion | Covidence | Rayyan | Elicit | INRA |
|---|---|---|---|---|
| Primary fit | Traditional systematic review management | Accessible screening and review triage | AI literature search and extraction | AI-assisted review workflow, source checking, and synthesis |
| Best user | Institutional teams, Cochrane-style workflows | Students, solo reviewers, small teams | Researchers mapping and extracting evidence | Review teams that need decisions, evidence, and writing to stay connected |
| Search and discovery | Mostly import-driven | Mostly import-driven | Strong AI search across large paper sets | Search, library, review workflow, and synthesis in one workspace |
| Screening | Structured title and abstract screening | Fast screening with AI relevance predictions | Dedicated systematic review workflow on Pro and higher plans | Human-controlled screening with AI support |
| Full-text review | Review workflow support, usually alongside external PDF handling | Available on paid plans | Useful for paper-level reasoning and summaries | Embedded PDF review with eligibility decisions in the same workspace |
| Data extraction | Structured extraction inside review workflow | Available on paid plans | Extraction tables and custom extractions | Structured extraction with source-linked values and reviewer control |
| Risk of bias | Mature systematic review workflow support | Risk of Bias feature listed by Rayyan | Not the main product center | Risk-of-bias assessment with AI suggestions inside SLR Copilot |
| PRISMA support | Core workflow output | Available on paid plans | PRISMA-grade claims on enterprise plan | PRISMA workflow and exports in SLR Copilot |
| AI role | Conservative, reviewer-centered assistance | Screening predictions and ResearchPilot on higher plans | Research Agent, reports, extraction, alerts | AI suggestions across screening, full text, extraction, risk of bias, and citation verification |
| Pricing note | $339 USD/year for one review on Covidence's current public pricing page | Free plan plus paid individual/team/institution plans | Free Basic, Plus, Pro, Scale, and Enterprise tiers | Professional subscription plus teams and institutions path |
Pricing and plan details change. Check the official pages before making a purchasing decision: Covidence pricing, Rayyan pricing, Elicit pricing, and INRA pricing.
Covidence: best for established review management
Covidence is the conservative choice for formal review teams. Its public pricing page currently lists a single-review plan at $339 USD per year and a package of up to three reviews at $907 USD per year. Every plan includes collaboration on a single review instance, imports from common reference tools, mobile screening, support, and online access.
The appeal is process discipline. A team can import references, screen, extract, assess quality, and export review data inside a workflow many librarians and evidence synthesis teams already know. That matters when the review has multiple reviewers, a methods section to defend, or an institutional sponsor.
Covidence is less compelling when the main problem is discovery, AI-heavy extraction, or turning the review into a polished synthesis draft. Most teams will still use databases, reference managers, writing tools, and sometimes AI assistants around it.
Rayyan: best for accessible screening
Rayyan is popular because it lowers the cost of getting started. Its current public pricing page lists a free plan for a first systematic review, with paid plans adding PRISMA diagrams, more reviewers, mobile access, auto-resolving duplicates, AI agents, PICO extraction, and institutional ResearchPilot features.
If your bottleneck is title and abstract screening, Rayyan can be a practical fit. It gives reviewers a focused workspace for include and exclude decisions and it has a large user base, which means many students and librarians have already seen it.
The tradeoff is scope. Rayyan is not trying to be your full writing and synthesis system. It helps you move through screening, but your team may still need separate tools for deep synthesis, citation verification, and drafting.
Elicit: best for AI evidence discovery and extraction
Elicit is different from Covidence and Rayyan. It is built around AI research assistance: search, paper summaries, automated reports, extraction tables, alerts, and systematic review workflows on higher plans. Elicit currently positions its Pro plan for systematic reviews and lists a dedicated workflow that can screen 5,000 papers.
That makes Elicit useful when you are still shaping the evidence map. It can help you find papers, ask questions across them, build extraction columns, and move faster through a broad research question.
Elicit is not a drop-in replacement for every traditional review management workflow. If your team needs strict reviewer voting, conflict resolution, risk-of-bias workflows, and institutional review controls, compare the plan details carefully before treating it as the whole system.
INRA: best when review work needs to become a source-backed report
INRA is built for researchers who need more than screening. SLR Copilot supports protocol-led systematic review work with citation import, screening, full-text review, extraction, risk of bias, and PRISMA-oriented exports. The broader INRA workspace also supports literature review generation, paper management, chat with research documents, and citation validation.
The practical difference is not only that INRA puts more steps in one product. It is that the evidence trail stays attached as work moves forward. A reviewer can move from papers to decisions to extraction to synthesis without constantly rebuilding context in separate tools. That matters when the output is a review, report, manuscript draft, or internal evidence brief.
AI across the review, not only at the search layer
INRA uses AI where review teams usually lose time: screening support, full-text interpretation, extraction pre-fill, and risk-of-bias suggestions. Reviewers still make the decisions.
Evidence stays attached to the source
Extraction work is designed around the paper, the field, and the supporting source context. That makes it easier to check whether a claim, quote, or extracted value really belongs in the review.
PDFs, decisions, and exports live together
The review workspace keeps full-text PDFs, eligibility votes, exclusion reasons, extraction fields, risk-of-bias judgments, and PRISMA outputs in one place.
The review can turn into a draft
Most screening tools stop once the review data is organized. INRA is built to carry the same sources into synthesis, citation validation, and writing.
The honest limitation is maturity. Covidence and Rayyan have had more time to build institutional familiarity. INRA is the better fit when AI-assisted workflow depth and writing continuity matter more than buying the oldest name in the category.
Try the workflow before you pick a tool
If you are comparing tools because a review is about to start, test the first hour of work: define the question, import citations, screen a sample, extract a few fields, and check how the output would feed your final report.
Which one should you choose?
Choose Covidence if your institution already uses it
Covidence is the safer default for teams that need an established workflow, library support, and a process reviewers already recognize. If your university pays for it and your protocol fits the standard review path, switching may not be worth the coordination cost.
Choose Rayyan if screening speed and access matter most
Rayyan is usually the easiest place to start when the main job is screening citations. The free tier lowers friction, and the interface is built around fast include and exclude decisions.
Choose Elicit if the hard part is finding and extracting evidence
Elicit is useful when you are still mapping a topic, building evidence tables, or asking questions across a paper set. It feels less like a classic review manager and more like an AI research assistant.
Choose INRA if the review needs to turn into a sourced report
INRA is strongest when screening is only one part of the job. It connects SLR workflow with full-text review, source-linked extraction, risk of bias, verified citations, and writing, so the work can move from papers to a usable draft without losing source control.
How to test the tools without wasting a week
Do not compare feature lists in isolation. Run a small pilot with the same references and the same review question. A fair test can be done in one afternoon.
- Pick 50 to 100 citations from the review topic.
- Import the same file into each candidate tool.
- Screen 20 records and record how many clicks it takes.
- Extract three fields from five papers.
- Check whether the tool preserves the source trail for each decision.
- Export the results and ask whether they would survive your methods section.
The winner is usually obvious after that. Some teams need the safest institutional path. Some need speed. Some need AI search. Some need a tool that can carry the work into synthesis.
FAQs
Is Rayyan better than Covidence?
Rayyan can be better for low-cost screening and quick individual workflows. Covidence is usually better for institutions that want a mature, structured systematic review process with established support.
Is Elicit a systematic review tool?
Elicit supports systematic review work, especially search, screening workflows, extraction, reports, and alerts. It is best understood as an AI research assistant with systematic review features rather than a traditional review management platform.
What is the best Covidence alternative?
The best Covidence alternative depends on the job. Rayyan is a strong alternative for screening, Elicit is strong for AI-assisted search and extraction, and INRA is a good fit when you want AI-assisted review workflow connected to synthesis and writing.
Can AI replace human reviewers in a systematic review?
No. AI can speed up screening, extraction, and summarization, but human reviewers still need to set eligibility criteria, resolve conflicts, check extracted data, judge risk of bias, and defend the methods.
Bottom line
Covidence is the strongest fit for established institutional review management. Rayyan is the easiest starting point for affordable screening. Elicit is strongest when AI search and extraction are the main job. INRA is the better fit when the review needs to become a sourced, written output inside the same research workflow.
If you are still early in the decision, start with the shape of the work. A screening-heavy student review, a library-backed Cochrane-style review, and an AI-assisted evidence brief do not need the same tool.
About the author
Marwan Taman is the founder and CEO of INRA.AI, where he builds AI systems for literature review and evidence synthesis. A software engineer by background, he is a co-author of an LLM-assisted health-literacy study presented at the American Stroke Association's International Stroke Conference 2026 and published in Stroke. He writes about AI, research workflows, and evidence synthesis. Connect on LinkedIn.
References
- Covidence pricing and feature information. covidence.org/pricing
- Rayyan pricing and feature information. rayyan.ai/pricing
- Elicit pricing and systematic review plan information. elicit.com/pricing
- Page MJ, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71. bmj.com
- Cochrane Handbook for Systematic Reviews of Interventions. training.cochrane.org/handbook